FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Biologics

2 Regenxbio Gene Therapies Get Clinical Holds

FDA places clinical holds on two Regenxbio investigational gene therapy programs for ultra-rare pediatric diseases following the identification of a c...

latest-news-card-1
Human Drugs

Boehringer Ingelheim Reports Data on Kidney Drug

Boehringer Ingelheim says its investigational kidney drug apecotrep reduced proteinuria by 40% compared with placebo in a Phase 2 clinical trial invol...

latest-news-card-1
Marketing

Neffy Broadcast Ad False or Misleading: OPDP

An FDA Untitled Letter cautions ARS Pharmaceutical about false or misleading claims for its Neffy nasal spray.

latest-news-card-1
Human Drugs

Public Citizen Sues Over Drug Price Deals

Public Citizen asks a federal court to order the Trump administration to make public the terms of drug pricing deals it signed with Pfizer and Lilly.

latest-news-card-1
Medical Devices

FDA Warns HIV Testing Companies on Collection Devices

An Akin legal update says FDAs recent issuance of Warning Letters to four direct-to-consumer testing companies over the use of unauthorized at-home bl...

latest-news-card-1
Human Drugs

FDA Cites Sterile Compounding Lapses at Nubratori

FDA cites Nubratori Inc. for multiple manufacturing and contamination-control deficiencies following a December inspection of the companys Torrance, C...

latest-news-card-1
Human Drugs

HHS OIG Outlines Safe Harbor for DTC Drug Sales

HHS Office of Inspector General issues new guidance clarifying when pharmaceutical manufacturers can sell prescription drugs directly to patients enro...

latest-news-card-1
Human Drugs

CGMP Issues at Malaysias Fulijaya Manufacturing

FDA warns Malaysias Fulijaya Manufacturing about CGMP violations in its production of finished drugs.

latest-news-card-1
Human Drugs

Using AI in Tumor Assessment

A Friends of Cancer Research white paper explores the emerging role of AI-enabled tumor assessment tools and the framework needed to use them in valid...

latest-news-card-1
Human Drugs

Roche Reports Positive Phase 2 Data for Obesity Drug

Roche says its experimental dual GLP-1/GIP receptor agonist CT-388 delivered substantial and statistically significant weight loss in a Phase 2 study ...